Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles E DiLiberti

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Contraception|December 18, 2007
Effects on serum hormone levels of low-dose estrogen in place of placebo during the hormone-free interval of an oral contraceptiveKathleen Z Reape, Charles E DiLiberti, Christopher H Hendy, et al.
Contraception|December 8, 2010
Steady-state pharmacokinetics of an extended-regimen oral contraceptive with continuous estrogenCharles E DiLiberti, Christine M O'Leary, Christopher H Hendy, et al.
Pharmaceutical Statistics|February 11, 2011
Additional results for 'Sequential design approaches for bioequivalence studies with crossover designs'Timothy H Montague, Diane Potvin, Charles E Diliberti, et al.
Pharmaceutical Statistics|August 22, 2007
Sequential design approaches for bioequivalence studies with crossover designsDiane Potvin, Charles E DiLiberti, Walter W Hauck, et al.
Menopause (New York, N.Y.)|November 26, 2010
A randomized, multiple-dose parallel study to compare the pharmacokinetic parameters of synthetic conjugated estrogens, A, administered as oral tablet or vaginal creamRupinder K Bhamra, Marya B Margolis, James H Liu, et al.
Pharmaceutical Statistics|November 6, 2015
Optimal adaptive sequential designs for crossover bioequivalence studiesJialin Xu, Charles Audet, Charles E DiLiberti, et al.
Clinical Pharmacology and Therapeutics|April 1, 2018
Model-Informed Drug Development and Review for Generic Products: Summary of FDA Public WorkshopLanyan Fang, Myong-Jin Kim, Zhichuan Li, et al.
Clinical Pharmacology and Therapeutics|November 25, 2020
Public Workshop Summary Report on Fiscal Year 2021 Generic Drug Regulatory Science Initiatives: Data Analysis and Model-Based BioequivalenceJieon Lee, Yuqing Gong, Sid Bhoopathy, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Contraception|December 18, 2007
Effects on serum hormone levels of low-dose estrogen in place of placebo during the hormone-free interval of an oral contraceptiveKathleen Z Reape, Charles E DiLiberti, Christopher H Hendy, et al.
Contraception|December 8, 2010
Steady-state pharmacokinetics of an extended-regimen oral contraceptive with continuous estrogenCharles E DiLiberti, Christine M O'Leary, Christopher H Hendy, et al.
Pharmaceutical Statistics|February 11, 2011
Additional results for 'Sequential design approaches for bioequivalence studies with crossover designs'Timothy H Montague, Diane Potvin, Charles E Diliberti, et al.
Pharmaceutical Statistics|August 22, 2007
Sequential design approaches for bioequivalence studies with crossover designsDiane Potvin, Charles E DiLiberti, Walter W Hauck, et al.
Menopause (New York, N.Y.)|November 26, 2010
A randomized, multiple-dose parallel study to compare the pharmacokinetic parameters of synthetic conjugated estrogens, A, administered as oral tablet or vaginal creamRupinder K Bhamra, Marya B Margolis, James H Liu, et al.
Pharmaceutical Statistics|November 6, 2015
Optimal adaptive sequential designs for crossover bioequivalence studiesJialin Xu, Charles Audet, Charles E DiLiberti, et al.
Clinical Pharmacology and Therapeutics|April 1, 2018
Model-Informed Drug Development and Review for Generic Products: Summary of FDA Public WorkshopLanyan Fang, Myong-Jin Kim, Zhichuan Li, et al.
Clinical Pharmacology and Therapeutics|November 25, 2020
Public Workshop Summary Report on Fiscal Year 2021 Generic Drug Regulatory Science Initiatives: Data Analysis and Model-Based BioequivalenceJieon Lee, Yuqing Gong, Sid Bhoopathy, et al.
Pageof 1